[18F]3F4AP for Imaging Demyelinating Conditions
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Age
- 18 – 90
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 105 (estimated)
- Sponsor
- Yale University · Other
This trial is looking for people between 18 and 90 years old. If you are in good health and understand what the study involves, you may be able to participate.
You may be able to join if
- I am at least 18 years old
- I am under 90 years old
- I can understand and give my consent to take part
- I am in good health
You may not be able to join if
- I am under 18 years old
- I am pregnant or breastfeeding
- I have a serious medical condition or am currently unwell
- I have a phobia of small spaces
- I had too much radiation exposure in the past year
- I have a bleeding disorder or take blood-thinning medications
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).
Loading trial locations…